[Federal Register Volume 73, Number 200 (Wednesday, October 15, 2008)]
[Notices]
[Page 61091]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-24488]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning Method and 
Kit for Detecting Adenovirus Serotype 14 Virus

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of the invention set forth in 
U.S. Provisional Patent Application Serial No. 61/058,598 entitled 
``Method and Kit for Detecting Adenovirus Serotype 14 Virus,'' filed 
June 4, 2008. The United States Government, as represented by the 
Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Adenovirus type 14 (Ad14) is an emerging 
pathogen that can cause life threatening diseases and large outbreaks. 
To improve the capability of the laboratory for diagnosing AD14 
infection and to prepare for possible outbreak, a real-time PCR assay 
targeting a unique sequence in the hexon region of the adenovirus 
genome is disclosed.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. E8-24488 Filed 10-14-08; 8:45 am]
BILLING CODE 3710-08-P